BOLD
Boundless Bio, Inc.
2.46
+0.01 (+0.41%)
52w low 0.9610
3.16 high
68.0% of range
Financial Analysis
| (USD) | Mar 25 | Jun 25 | Sep 25 | Dec 25 | Mar 26 | Jun 26 | Trend |
|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -- | -11.83M | -10.20M | -10.11M | -14.97M | -20.97M | |
| Depreciation & Amort | -- | 317.00K | 310.00K | 307.00K | 284.00K | 1.26M | |
| Capital Expenditure | -- | -48.00K | -15.00K | -424.00K | -8.00K | -38.00K | |
| Free Cash Flow | -- | -11.88M | -10.21M | -10.53M | -14.98M | -21.01M | |
| Investing Cash Flow | -- | 11.29M | 10.48M | 12.97M | 14.59M | 23.07M | |
| Financing Cash Flow | -- | 117.00K | 0.00 | 24.00K | 0.00 | 73.00K |
Revenue CAGR
--
Net Income CAGR
--
EPS CAGR
--
FCF CAGR
--
Revenue YoY
--